From mouse to man: Redefining the role of insulin-like growth factor-I in the acquisition of bone mass

Shoshana Yakar, Clifford J. Rosen

Research output: Contribution to journalArticle

Abstract

The insulin-like growth factor system (IGF) has been linked to the process of bone acquisition through epidemiologic analyses of large cohorts and in vitro studies of bone cells. But the exact relationship between expression of IGF-I in bone and skeletal homeostasis or pathologic conditions, such as osteoporosis, remains poorly defined. Recent advances in genomic engineering have resulted in the development of better in vivo models to test the role of IGF-I during development and maintenance of the adult skeleton. It is now established that skeletal expression of IGF-I is critical for differentiative bone cell function. It may also be essential for the full anabolic effects of parathyroid hormone on trabecular bone and for some component of biomineralization. Evidence from conditional mutagenesis studies suggests that serum IGF-I may represent more than a storage depot or permissive factor during the final phase of skeletal acquisition. This work re-examines the original tenets of the "somatomedin hypothesis" in light of these newer mouse models and their remarkable skeletal phenotypes. The implications are far reaching and suggest that newer approaches for manipulating the IGF regulatory system may one day be useful as therapeutic adjuncts for the treatment of osteoporosis.

Original languageEnglish (US)
Pages (from-to)245-252
Number of pages8
JournalExperimental Biology and Medicine
Volume228
Issue number3
StatePublished - Mar 2003

Fingerprint

Somatomedins
Insulin-Like Growth Factor I
Bone
Bone and Bones
Osteoporosis
Anabolic Agents
Parathyroid Hormone
Skeleton
Mutagenesis
Homeostasis
Cohort Studies
Biomineralization
Maintenance
Phenotype
Serum
Therapeutics

Keywords

  • Bone volume
  • Conditional mutagenesis
  • IGF-I
  • Osteoblasts
  • Periosteum

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

From mouse to man : Redefining the role of insulin-like growth factor-I in the acquisition of bone mass. / Yakar, Shoshana; Rosen, Clifford J.

In: Experimental Biology and Medicine, Vol. 228, No. 3, 03.2003, p. 245-252.

Research output: Contribution to journalArticle

@article{7d3475238ba943ae96eefef6af88a7b8,
title = "From mouse to man: Redefining the role of insulin-like growth factor-I in the acquisition of bone mass",
abstract = "The insulin-like growth factor system (IGF) has been linked to the process of bone acquisition through epidemiologic analyses of large cohorts and in vitro studies of bone cells. But the exact relationship between expression of IGF-I in bone and skeletal homeostasis or pathologic conditions, such as osteoporosis, remains poorly defined. Recent advances in genomic engineering have resulted in the development of better in vivo models to test the role of IGF-I during development and maintenance of the adult skeleton. It is now established that skeletal expression of IGF-I is critical for differentiative bone cell function. It may also be essential for the full anabolic effects of parathyroid hormone on trabecular bone and for some component of biomineralization. Evidence from conditional mutagenesis studies suggests that serum IGF-I may represent more than a storage depot or permissive factor during the final phase of skeletal acquisition. This work re-examines the original tenets of the {"}somatomedin hypothesis{"} in light of these newer mouse models and their remarkable skeletal phenotypes. The implications are far reaching and suggest that newer approaches for manipulating the IGF regulatory system may one day be useful as therapeutic adjuncts for the treatment of osteoporosis.",
keywords = "Bone volume, Conditional mutagenesis, IGF-I, Osteoblasts, Periosteum",
author = "Shoshana Yakar and Rosen, {Clifford J.}",
year = "2003",
month = "3",
language = "English (US)",
volume = "228",
pages = "245--252",
journal = "Experimental Biology and Medicine",
issn = "1535-3702",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - From mouse to man

T2 - Redefining the role of insulin-like growth factor-I in the acquisition of bone mass

AU - Yakar, Shoshana

AU - Rosen, Clifford J.

PY - 2003/3

Y1 - 2003/3

N2 - The insulin-like growth factor system (IGF) has been linked to the process of bone acquisition through epidemiologic analyses of large cohorts and in vitro studies of bone cells. But the exact relationship between expression of IGF-I in bone and skeletal homeostasis or pathologic conditions, such as osteoporosis, remains poorly defined. Recent advances in genomic engineering have resulted in the development of better in vivo models to test the role of IGF-I during development and maintenance of the adult skeleton. It is now established that skeletal expression of IGF-I is critical for differentiative bone cell function. It may also be essential for the full anabolic effects of parathyroid hormone on trabecular bone and for some component of biomineralization. Evidence from conditional mutagenesis studies suggests that serum IGF-I may represent more than a storage depot or permissive factor during the final phase of skeletal acquisition. This work re-examines the original tenets of the "somatomedin hypothesis" in light of these newer mouse models and their remarkable skeletal phenotypes. The implications are far reaching and suggest that newer approaches for manipulating the IGF regulatory system may one day be useful as therapeutic adjuncts for the treatment of osteoporosis.

AB - The insulin-like growth factor system (IGF) has been linked to the process of bone acquisition through epidemiologic analyses of large cohorts and in vitro studies of bone cells. But the exact relationship between expression of IGF-I in bone and skeletal homeostasis or pathologic conditions, such as osteoporosis, remains poorly defined. Recent advances in genomic engineering have resulted in the development of better in vivo models to test the role of IGF-I during development and maintenance of the adult skeleton. It is now established that skeletal expression of IGF-I is critical for differentiative bone cell function. It may also be essential for the full anabolic effects of parathyroid hormone on trabecular bone and for some component of biomineralization. Evidence from conditional mutagenesis studies suggests that serum IGF-I may represent more than a storage depot or permissive factor during the final phase of skeletal acquisition. This work re-examines the original tenets of the "somatomedin hypothesis" in light of these newer mouse models and their remarkable skeletal phenotypes. The implications are far reaching and suggest that newer approaches for manipulating the IGF regulatory system may one day be useful as therapeutic adjuncts for the treatment of osteoporosis.

KW - Bone volume

KW - Conditional mutagenesis

KW - IGF-I

KW - Osteoblasts

KW - Periosteum

UR - http://www.scopus.com/inward/record.url?scp=0037338638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037338638&partnerID=8YFLogxK

M3 - Article

C2 - 12626768

AN - SCOPUS:0037338638

VL - 228

SP - 245

EP - 252

JO - Experimental Biology and Medicine

JF - Experimental Biology and Medicine

SN - 1535-3702

IS - 3

ER -